Literature DB >> 35362458

A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan.

Seo Yeon Yoo1, Jihun Kim2, Kee Wook Jung1.   

Abstract

Entities:  

Year:  2022        PMID： 35362458      PMCID： PMC8978126          DOI： 10.5056/jnm21161

Source DB:  PubMed          Journal:  J Neurogastroenterol Motil        ISSN： 2093-0879            Impact factor:   4.924


× No keyword cloud information.
  9 in total

1.  Severe spruelike enteropathy associated with olmesartan.

Authors:  Alberto Rubio-Tapia; Margot L Herman; Jonas F Ludvigsson; Darlene G Kelly; Thomas F Mangan; Tsung-Teh Wu; Joseph A Murray
Journal:  Mayo Clin Proc       Date:  2012-06-22       Impact factor: 7.616

2.  Angiotensin II induces apoptosis in intestinal epithelial cells through the AT2 receptor, GATA-6 and the Bax pathway.

Authors:  Lihua Sun; Wensheng Wang; Weidong Xiao; Hongyin Liang; Yang Yang; Hua Yang
Journal:  Biochem Biophys Res Commun       Date:  2012-07-07       Impact factor: 3.575

3.  New Onset Villous Atrophy in a Patient With Celiac Disease.

Authors:  Amanda K Cartee; Juan P Reyes Genere; Amy S Oxentenko
Journal:  Gastroenterology       Date:  2018-07-17       Impact factor: 22.682

Review 4.  Systematic review: Sprue-like enteropathy associated with olmesartan.

Authors:  G Ianiro; S Bibbò; M Montalto; R Ricci; A Gasbarrini; G Cammarota
Journal:  Aliment Pharmacol Ther       Date:  2014-05-07       Impact factor: 8.171

Review 5.  Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology.

Authors:  Nina Burbure; Benjamin Lebwohl; Carolina Arguelles-Grande; Peter H R Green; Govind Bhagat; Stephen Lagana
Journal:  Hum Pathol       Date:  2015-12-19       Impact factor: 3.466

Review 6.  Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.

Authors:  Eun-Young Karen Choi; Barbara J McKenna
Journal:  Arch Pathol Lab Med       Date:  2015-10       Impact factor: 5.534

Review 7.  Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review.

Authors:  Ayesha Kamal; Christopher Fain; Angela Park; Peiqi Wang; Eduardo Gonzalez-Velez; Daniel A Leffler; Susan M Hutfless
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-01

8.  Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study.

Authors:  Seng Chan You; Hojun Park; Dukyong Yoon; Sooyoung Park; Boyoung Joung; Rae Woong Park
Journal:  Korean J Intern Med       Date:  2017-11-27       Impact factor: 2.884

9.  Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.

Authors:  Harshal Surendra Mandavdhare; Vishal Sharma; Kaushal K Prasad; Amit Kumar; Manish Rathi; Surinder S Rana
Journal:  Intest Res       Date:  2017-06-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.